Related Experiment Video

Updated: May 25, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Predicting and preventing cardiovascular disease in HIV-infected patients

Wendy S Post1

  • 1The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Topics in Antiviral Medicine
|February 3, 2012
PubMed

Insights

Cardiovascular disease (CVD) is the leading cause of death for people with HIV. Managing traditional CVD risk factors is crucial for this population, following current national guidelines.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in individuals with HIV, surpassing non-HIV-related causes.
  • The elevated CVD risk in HIV-infected individuals stems from traditional risk factors, chronic inflammation from HIV, and antiretroviral therapy side effects.
  • Traditional CVD risk factors are the predominant drivers of risk in HIV-positive patients, who often present with a high prevalence of these conditions.

Purpose of the Study:

  • To summarize current understanding and management strategies for cardiovascular disease in HIV-infected individuals.
  • To emphasize the significant role of traditional cardiovascular risk factors in this population.
  • To provide guidance on managing cardiovascular risk factors in HIV-infected persons based on existing national guidelines.

Main Methods:

  • Review of existing literature and clinical evidence regarding CVD in HIV-infected populations.
  • Synthesis of information presented at the 14th Annual Clinical Conference for the Ryan White HIV/AIDS Program.
  • Discussion of the interplay between HIV infection, traditional risk factors, and CVD.

Main Results:

  • Traditional cardiovascular risk factors are the major determinants of CVD risk in HIV-infected patients.
  • While HIV may be an independent risk factor, evidence is insufficient to classify it as a coronary heart disease risk equivalent.
  • Current national guidelines for managing dyslipidemia, hypertension, and metabolic syndrome should be applied to HIV-infected individuals.

Conclusions:

  • HIV-infected individuals face a high burden of traditional cardiovascular risk factors.
  • Management of CVD in HIV-infected persons should align with established national guidelines for risk factor treatment.
  • Further research may be needed to fully elucidate HIV's independent role in CVD development.

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...